FINHUB Insights

ZTS · Q2 FY25 · Apr 1 – Jun 30, 2025

Zoetis Q2 FY25: where the revenue came from and where it went

Zoetis Q2 FY25: revenue $2.5B (+4% year over year). Net profit $0.7B. Largest cohort Livestock $0.6B. The whole income statement as a sankey diagram from the SEC filing.

Period
Apr 1 – Jun 30, 2025
Reported
Aug 5, 2025 10-Q
Sankey diagram of Zoetis's income statement for Q2 FY25: revenue of $2.5 billion splits into segments and flows out into costs, taxes and net profit.

Tap the diagram to enlarge · figures in billions of dollars

Revenue$2.5B +4% year over year
Gross profit$1.8B 74% margin
Operating profit$0.9B 37% margin
Net profit$0.7B 29% margin

The numbers

All figures in billions of U.S. dollars, for Q2 FY25 (period ends Jun 30, 2025).
ItemValueShare of revenueYear over year
Revenue 2.5 100% +4%
Livestock 0.6 24% −8%
Dermatology 0.5 20% +11%
Cattle 0.3 12%
Other 0.3 12%
Anti Infective Products 0.2 8% −17%
Pain Sedation 0.2 8% −2%
Swine 0.1 4% −8%
Animal Health Diagnostics 0.1 4% +7%
Cost of revenue−0.624%
Gross profit1.874% margin+2pp
SG&A−0.625%+0pp
Other−0.312%+0pp
Operating profit0.937% margin+3pp
Tax−0.2
Net profit0.729%+3pp
Filing on EDGAR More quarters of ZTS

Source of the numbers: structured XBRL data from the filing (10-Q). The diagram is generated automatically and checked against EDGAR before release. How we calculate it → About and methodology.

Older quarters